US antiviral giant Gilead Sciences on Friday unveiled two-and-a-half-year interim analysis from the ongoing Phase III ASSURE ...

Health stocks slumped on Friday as Wall Street weighed the impact that prominent vaccine skeptic Robert F. Kennedy Jr. could ...

The Indo-French Chamber of Commerce and industry (IFCCI) celebrated the most impactful CSR initiatives by French and Indian ...

Manila Water Foundation Joins Erceflora Probiotics and Save the Children Philippines to Expand Hygiene and Water Access for ...

The now defunct airline issued over 93,000 “First Moon Flights” Club cards to those who wanted a seat on the first commercial ...

AstraZeneca and GSK fell as the president-elect named Kennedy as his pick for the role overseeing the US's rules on medicine, ...

ABC News’ Phil Lipof speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug ...

European shares fell on Friday, dragged down by disappointing earnings, concerns about the impact of U.S. President-elect Donald Trump's policies, and a jump in Treasury yields. Investors were also ...

The company also finalized a collaboration agreement with Sanofi and settled previous repurchase obligations, streamlining its operations. Despite a net loss from continuing operations of $38.9 ...

EMA human medicine committee recommends approval of Sanofi’s Sarclisa to treat transplant-ineligible newly diagnosed multiple myeloma: Paris Saturday, November 16, 2024, 09:00 H ...

(Reuters) - Europe's STOXX 600 opened lower on Friday, dragged by technology and healthcare stocks, keeping the index on ...

French drug company Sanofi, whose website boasts its products vaccinate over 500 million annually, tumbled nearly 3.5%. With uncertainty over the direction of their agencies, many older scientists at ...